Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $441.26 Million |
|---|---|
| Enterprise Value | - |
| Annual dividend | $0.43 |
| Dividend yield | 0.51% |
| Earnings per Share | $- |
| Beta | 0.61 |
| Outstanding Shares | - |
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
No data
No data available for the latest quarter.
No data available for the latest quarter.
This fund's primary objective is to generate daily investment returns that are one and a half times (1.5x) the daily movement of the Dow Jones U.S. BiotechnologySM Index, before any deductions for fees and expenses. To achieve this lever...